News

‘Orphan Black’ Season 4 Release Date & Spoilers: Castor Clone Mark to Return; Delphine’s Gunshot Wound Not Fatal? Cast & Crew Tease Details at PaleyFest

The cast and crew of the Canadian TV series "Orphan Black," which also airs on BBC, recently attended the PaleyFest New York. In the event, it was revealed that the main Castor clone Mark (Ari Millen) will return in Season 4. Meanwhile, another character who may make a comeback is Delphine (Evelyne Brochu), who was shot in the Season 3 finale episode of the show.

In Season 3, the LEDA clones, led by Sarah (Tatiana Maslany), had to fight the Castor clones, which turned out to be their brothers after all. The main Castor clone Mark, played by Millen, helped Sarah and her sisters against Castor. However, what happened to the character afterward was not specifically revealed as Season 3 came to a close.

In the PaleyFest, however, it was revealed that Millen's character will return in Season 4, and according to Christian Today, he will be responsible for a big twist. Whether such twist is advantageous to Sarah and her sisters or not is yet to be seen.

Meanwhile, Delphine's fate in the TV series hangs in the air as she appeared to have died as she was shot in the Season 3 finale episode. Most fans are wondering if she's still alive, while others believe that she is indeed dead.

However, according to International Business Times, the show's executive producer Graeme Manson hinted the possibility that the character is still alive, noting that it's great that people are invested in Delphine's fate. "Where did she get hit? In the liver? I don't think that's necessarily fatal," he added.  

The publication also noted that the "Orphan Black" Season 4 teaser from the PaleyFest also teased that Delphine may be alive. However, if she does turn out to have survived the gunshots, her relationship with Cosima is a different story altogether.

"Orphan Black" Season 4 is set to return in 2016. However, no official premiere date has been set yet as the show is currently still in production.  


Join the Discussion
Real Time Analytics